Rare diseases
Investigational molecules
Locations
Back to France651 clinical trials in Clermont Ferrand, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence
FranceStudy on Dostarlimab to Prevent Second Cancer in Patients Cured from Primary Cancer
FranceStudy on the Safety of Ivosidenib and Azacitidine for Adults with Newly Diagnosed IDH1m Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy
FranceStudy on Switching HIV Treatment to Doravirine and Islatravir for Patients with HIV-1
FranceStudy on Early Detection of Triple-Negative Breast Cancer Relapse Using [68Ga]Ga-FAPI-46 for Patients at High Risk
FranceStudy on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa
FranceStudy comparing XL092 plus nivolumab versus sunitinib for patients with advanced or metastatic non-clear cell kidney cancer
FranceStudy of Baricitinib for Treating Hospital-Acquired Pneumonia in Critically Ill Patients with a Proinflammatory Profile
FranceStudy on Spironolactone for Patients with Arrhythmogenic Right Ventricular Dysplasia (ARVD)
FranceStudy on Pegaspargase for Treating Acute Lymphoblastic Leukemia in Children and Adolescents
FranceStudy of Rituximab compared to placebo in patients with anti-MAG neuropathy who are likely to respond well to treatment
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on inflammatory bowel diseases including groundbreaking trials examining fecal microbiota transplantation in both Crohn's disease and ulcerative colitis. Research aims to evaluate new therapeutic approaches for patients with moderate to severe conditions.
These trials are exploring alternative treatment pathways for patients who have not responded to conventional therapies.
Comprehensive research in multiple myeloma and various cancer types, including innovative treatments for esophageal squamous cell carcinoma and pleural mesothelioma. Studies evaluate new therapeutic combinations and maintenance strategies.
Focus on improving patient outcomes through targeted therapies and immunological approaches.
Advanced research into rheumatoid arthritis and multiple sclerosis, investigating optimized treatment protocols and maintenance therapies. Studies aim to improve long-term disease management and patient quality of life.
Emphasis on developing more effective and tolerable treatment regimens.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
